Sfoglia per Autore
Design, Synthesis, and Pharmacological Characterization of Indol-3-ylacetamides, Indol-3-yloxoacetamides, and Indol-3-ylcarboxamides: Potent and Selective CB2 Cannabinoid Receptor Inverse Agonists
file con accesso da definire2012 Pasquini, S; Mugnaini, C; Ligresti, A; Tafi, A; Brogi, S; Falciani, C; Pedani, V; Pesco, N; Guida, F; Luongo, L; Varani, Katia; Borea, Pa; Maione, S; Di Marzo, V; Corelli, F.
Positive allosteric modulation of A1 adenosine receptors as a novel and promising therapeutic strategy for anxiety
2016 Vincenzi, Fabrizio; Ravani, Annalisa; Pasquini, Silvia; Merighi, Stefania; Gessi, Stefania; Romagnoli, Romeo; Baraldi, Pier Giovanni; Borea, Pier Andrea; Varani, Katia
Pulsed Electromagnetic Field Exposure Reduces Hypoxia and Inflammation Damage in Neuron-Like and Microglial Cells
2017 Vincenzi, Fabrizio; Ravani, Annalisa; Pasquini, Silvia; Merighi, Stefania; Gessi, Stefania; Setti, Stefania; Cadossi, Ruggero; Borea, Pier Andrea; Varani, Katia
The role of 5-arylalkylamino- and 5-piperazino- moieties on the 7-aminopyrazolo[4,3-d]pyrimidine core in affecting adenosine A1 and A2A receptor affinity and selectivity profiles
file con accesso da definire2017 Squarcialupi, Lucia; Betti, Marco; Catarzi, Daniela; Varano, Flavia; Falsini, Matteo; Ravani, Annalisa; Pasquini, Silvia; Vincenzi, Fabrizio; Salmaso, Veronica; Sturlese, Mattia; Varani, Katia; Moro, Stefano; Colotta, Vittoria
Adenosine Receptors as a Biological Pathway for the Anti-Inflammatory and Beneficial Effects of Low Frequency Low Energy Pulsed Electromagnetic Fields
file con accesso da definire2017 Varani, Katia; Vincenzi, Fabrizio; Ravani, Annalisa; Pasquini, Silvia; Merighi, Stefania; Gessi, Stefania; Setti, Stefania; Cadossi, Matteo; Borea, Pier Andrea; Cadossi, Ruggero
Role and function of A2A and A3 adenosine receptors in patients with ankylosing spondylitis, psoriatic arthritis and rheumatoid arthritis
2017 Ravani, Annalisa; Vincenzi, Fabrizio; Bortoluzzi, Alessandra; Padovan, Melissa; Pasquini, Silvia; Gessi, Stefania; Merighi, Stefania; Borea, Pier Andrea; Govoni, Marcello; Varani, Katia
Structure-activity relationship studies and pharmacological characterization of N5-heteroarylalkyl-substituted-2-(2-furanyl)thiazolo[5,4-d]pyrimidine-5,7-diamine-based derivatives as inverse agonists at human A2Aadenosine receptor
2018 Varano, Flavia; Catarzi, Daniela; Vincenzi, Fabrizio; Falsini, Matteo; Pasquini, Silvia; Borea, Pier Andrea; Colotta, Vittoria; Varani, Katia
Identification of novel thiazolo[5,4-d]pyrimidine derivatives as human A1and A2A adenosine receptor antagonists/inverse agonists
2018 Varano, Flavia; Catarzi, Daniela; Falsini, Matteo; Vincenzi, Fabrizio; Pasquini, Silvia; Varani, Katia; Colotta, Vittoria
Development of novel pyridazinone-based adenosine receptor ligands
2018 Catarzi, Daniela; Varano, Flavia; Falsini, Matteo; Varani, Katia; Vincenzi, Fabrizio; Pasquini, Silvia; Dal Ben, Diego; Colotta, Vittoria
Amino-3, 5-dicyanopyridines targeting the adenosine receptors ranging from pan ligands to combined A1/A2B partial agonists
2019 Catarzi, D.; Varano, F.; Varani, K.; Vincenzi, F.; Pasquini, S.; Dal Ben, D.; Volpini, R.; Colotta, V.
Modifications on the amino-3,5-dicyanopyridine core to obtain multifaceted adenosine receptor ligands with antineuropathic activity
2019 Betti, M.; Catarzi, D.; Varano, F.; Falsini, M.; Varani, K.; Vincenzi, F.; Pasquini, S.; Di Cesare Mannelli, L.; Ghelardini, C.; Lucarini, E.; Dal Ben, D.; Spinaci, A.; Bartolucci, G.; Menicatti, M.; Colotta, V.
A1 Adenosine Receptor Partial Agonists and Allosteric Modulators: Advancing Toward the Clinic?
2020 Vincenzi, F.; Pasquini, S.; Battistello, E.; Merighi, S.; Gessi, S.; Borea, P. A.; Varani, K.
Targeting adenosine receptors: A potential pharmacological avenue for acute and chronic pain
2020 Vincenzi, F.; Pasquini, S.; Borea, P. A.; Varani, K.
Adenosinergic System Involvement in Ischemic Stroke Patients' Lymphocytes
2020 Pasquini, S.; Vincenzi, F.; Casetta, I.; Laudisi, M.; Merighi, S.; Gessi, S.; Borea, P. A.; Varani, K.
Piperazine-and piperidine-containing thiazolo[5,4-d]pyrimidine derivatives as new potent and selective adenosine a2a receptor inverse agonists
2020 Varano, F.; Catarzi, D.; Vigiani, E.; Vincenzi, F.; Pasquini, S.; Varani, K.; Colotta, V.
The Detrimental Action of Adenosine on Glutamate-Induced Cytotoxicity in PC12 Cells Can Be Shifted towards a Neuroprotective Role through A1AR Positive Allosteric Modulation
2020 Vincenzi, F.; Pasquini, S.; Gessi, S.; Merighi, S.; Romagnoli, R.; Borea, P. A.; Varani, K.
Structural investigation on thiazolo[5,4-d]pyrimidines to obtain dual-acting blockers of CD73 and adenosine A2A receptor as potential antitumor agents
2020 Varano, F.; Catarzi, D.; Vincenzi, F.; Pasquini, S.; Pelletier, J.; Lopes Rangel Fietto, J.; Espindola Gelsleichter, N.; Sarlandie, M.; Guilbaud, A.; Sevigny, J.; Varani, K.; Colotta, V.
Pulsed electromagnetic fields stimulate hif-1α-independent vegf release in 1321n1 human astrocytes protecting neuron-like sh-sy5y cells from oxygen-glucose deprivation
2020 Vincenzi, F.; Pasquini, S.; Setti, S.; Salati, S.; Cadossi, R.; Borea, P. A.; Varani, K.
The role of adenosinergic system in brain ischemia
2020 Pasquini, Silvia
An Open Question: Is the A2A Adenosine Receptor a Novel Target for Alzheimer's Disease Treatment?
2021 Merighi, Stefania; Poloni, Tino Emanuele; Pelloni, Lucia; Pasquini, Silvia; Varani, Katia; Vincenzi, Fabrizio; Borea, Pier Andrea; Gessi, Stefania
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Design, Synthesis, and Pharmacological Characterization of Indol-3-ylacetamides, Indol-3-yloxoacetamides, and Indol-3-ylcarboxamides: Potent and Selective CB2 Cannabinoid Receptor Inverse Agonists | 2012 | Pasquini, S; Mugnaini, C; Ligresti, A; Tafi, A; Brogi, S; Falciani, C; Pedani, V; Pesco, N; Guida..., F; Luongo, L; Varani, Katia; Borea, Pa; Maione, S; Di Marzo, V; Corelli, F. | file con accesso da definire |
| Positive allosteric modulation of A1 adenosine receptors as a novel and promising therapeutic strategy for anxiety | 2016 | Vincenzi, Fabrizio; Ravani, Annalisa; Pasquini, Silvia; Merighi, Stefania; Gessi, Stefania; Romag...noli, Romeo; Baraldi, Pier Giovanni; Borea, Pier Andrea; Varani, Katia | |
| Pulsed Electromagnetic Field Exposure Reduces Hypoxia and Inflammation Damage in Neuron-Like and Microglial Cells | 2017 | Vincenzi, Fabrizio; Ravani, Annalisa; Pasquini, Silvia; Merighi, Stefania; Gessi, Stefania; Setti..., Stefania; Cadossi, Ruggero; Borea, Pier Andrea; Varani, Katia | |
| The role of 5-arylalkylamino- and 5-piperazino- moieties on the 7-aminopyrazolo[4,3-d]pyrimidine core in affecting adenosine A1 and A2A receptor affinity and selectivity profiles | 2017 | Squarcialupi, Lucia; Betti, Marco; Catarzi, Daniela; Varano, Flavia; Falsini, Matteo; Ravani, Ann...alisa; Pasquini, Silvia; Vincenzi, Fabrizio; Salmaso, Veronica; Sturlese, Mattia; Varani, Katia; Moro, Stefano; Colotta, Vittoria | file con accesso da definire |
| Adenosine Receptors as a Biological Pathway for the Anti-Inflammatory and Beneficial Effects of Low Frequency Low Energy Pulsed Electromagnetic Fields | 2017 | Varani, Katia; Vincenzi, Fabrizio; Ravani, Annalisa; Pasquini, Silvia; Merighi, Stefania; Gessi, ...Stefania; Setti, Stefania; Cadossi, Matteo; Borea, Pier Andrea; Cadossi, Ruggero | file con accesso da definire |
| Role and function of A2A and A3 adenosine receptors in patients with ankylosing spondylitis, psoriatic arthritis and rheumatoid arthritis | 2017 | Ravani, Annalisa; Vincenzi, Fabrizio; Bortoluzzi, Alessandra; Padovan, Melissa; Pasquini, Silvia;... Gessi, Stefania; Merighi, Stefania; Borea, Pier Andrea; Govoni, Marcello; Varani, Katia | |
| Structure-activity relationship studies and pharmacological characterization of N5-heteroarylalkyl-substituted-2-(2-furanyl)thiazolo[5,4-d]pyrimidine-5,7-diamine-based derivatives as inverse agonists at human A2Aadenosine receptor | 2018 | Varano, Flavia; Catarzi, Daniela; Vincenzi, Fabrizio; Falsini, Matteo; Pasquini, Silvia; Borea, P...ier Andrea; Colotta, Vittoria; Varani, Katia | |
| Identification of novel thiazolo[5,4-d]pyrimidine derivatives as human A1and A2A adenosine receptor antagonists/inverse agonists | 2018 | Varano, Flavia; Catarzi, Daniela; Falsini, Matteo; Vincenzi, Fabrizio; Pasquini, Silvia; Varani, ...Katia; Colotta, Vittoria | |
| Development of novel pyridazinone-based adenosine receptor ligands | 2018 | Catarzi, Daniela; Varano, Flavia; Falsini, Matteo; Varani, Katia; Vincenzi, Fabrizio; Pasquini, S...ilvia; Dal Ben, Diego; Colotta, Vittoria | |
| Amino-3, 5-dicyanopyridines targeting the adenosine receptors ranging from pan ligands to combined A1/A2B partial agonists | 2019 | Catarzi, D.; Varano, F.; Varani, K.; Vincenzi, F.; Pasquini, S.; Dal Ben, D.; Volpini, R.; Colott...a, V. | |
| Modifications on the amino-3,5-dicyanopyridine core to obtain multifaceted adenosine receptor ligands with antineuropathic activity | 2019 | Betti, M.; Catarzi, D.; Varano, F.; Falsini, M.; Varani, K.; Vincenzi, F.; Pasquini, S.; Di Cesar...e Mannelli, L.; Ghelardini, C.; Lucarini, E.; Dal Ben, D.; Spinaci, A.; Bartolucci, G.; Menicatti, M.; Colotta, V. | |
| A1 Adenosine Receptor Partial Agonists and Allosteric Modulators: Advancing Toward the Clinic? | 2020 | Vincenzi, F.; Pasquini, S.; Battistello, E.; Merighi, S.; Gessi, S.; Borea, P. A.; Varani, K. | |
| Targeting adenosine receptors: A potential pharmacological avenue for acute and chronic pain | 2020 | Vincenzi, F.; Pasquini, S.; Borea, P. A.; Varani, K. | |
| Adenosinergic System Involvement in Ischemic Stroke Patients' Lymphocytes | 2020 | Pasquini, S.; Vincenzi, F.; Casetta, I.; Laudisi, M.; Merighi, S.; Gessi, S.; Borea, P. A.; Varan...i, K. | |
| Piperazine-and piperidine-containing thiazolo[5,4-d]pyrimidine derivatives as new potent and selective adenosine a2a receptor inverse agonists | 2020 | Varano, F.; Catarzi, D.; Vigiani, E.; Vincenzi, F.; Pasquini, S.; Varani, K.; Colotta, V. | |
| The Detrimental Action of Adenosine on Glutamate-Induced Cytotoxicity in PC12 Cells Can Be Shifted towards a Neuroprotective Role through A1AR Positive Allosteric Modulation | 2020 | Vincenzi, F.; Pasquini, S.; Gessi, S.; Merighi, S.; Romagnoli, R.; Borea, P. A.; Varani, K. | |
| Structural investigation on thiazolo[5,4-d]pyrimidines to obtain dual-acting blockers of CD73 and adenosine A2A receptor as potential antitumor agents | 2020 | Varano, F.; Catarzi, D.; Vincenzi, F.; Pasquini, S.; Pelletier, J.; Lopes Rangel Fietto, J.; Espi...ndola Gelsleichter, N.; Sarlandie, M.; Guilbaud, A.; Sevigny, J.; Varani, K.; Colotta, V. | |
| Pulsed electromagnetic fields stimulate hif-1α-independent vegf release in 1321n1 human astrocytes protecting neuron-like sh-sy5y cells from oxygen-glucose deprivation | 2020 | Vincenzi, F.; Pasquini, S.; Setti, S.; Salati, S.; Cadossi, R.; Borea, P. A.; Varani, K. | |
| The role of adenosinergic system in brain ischemia | 2020 | Pasquini, Silvia | |
| An Open Question: Is the A2A Adenosine Receptor a Novel Target for Alzheimer's Disease Treatment? | 2021 | Merighi, Stefania; Poloni, Tino Emanuele; Pelloni, Lucia; Pasquini, Silvia; Varani, Katia; Vincen...zi, Fabrizio; Borea, Pier Andrea; Gessi, Stefania |
Legenda icone
- file ad accesso aperto
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile